The challenge of palmoplantar pustulosis therapy: Are Interleukin‐23 inhibitors an option?. (18th August 2021) - Poortinga, S.; Balakirski, G.; Kromer, C.; Mössner, R.; Schön, M.P.; Bieber, T.; Wilsmann‐Theis, D.